Agency for Healthcare Research and Quality Notice of Meetings, 18540-18541 [2019-08764]
Download as PDF
18540
Federal Register / Vol. 84, No. 84 / Wednesday, May 1, 2019 / Notices
confidentiality, and integrity of such
personal information.
Part III of the proposed order requires
any business that Mr. Grago controls,
directly or indirectly, that collects
personal information online to obtain
initial and biennial data security
assessments for twenty years.
Part IV of the agreement prohibits
Respondent from misrepresenting any
fact material to the assessments required
by Provision III.
Part V requires any business that Mr.
Grago controls directly or indirectly,
including ClixSense, to submit an
annual certification from a senior
corporate manager (or senior officer
responsible for its information security
program) that Respondent has
implemented the requirements of the
Order and is not aware of any material
noncompliance that has not been
corrected or disclosed to the
Commission.
Parts VI through IX of the proposed
order are reporting and compliance
provisions, which include
recordkeeping requirements and
provisions requiring Respondent to
provide information or documents
necessary for the Commission to
monitor compliance. Part X states that
the proposed order will remain in effect
for 20 years, with certain exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the complaint
or proposed order, or to modify in any
way the proposed order’s terms.
By direction of the Commission.
Julie A. Mack,
Acting Secretary.
[FR Doc. 2019–08786 Filed 4–30–19; 8:45 am]
jbell on DSK30RV082PROD with NOTICES
Statement of the Federal Trade
Commission
BILLING CODE 6750–01–P
April 24, 2019
Today, the Commission announces
cases against ClixSense and i-Dressup,1
which include allegations that the
companies failed to employ reasonable
security to protect consumers’ sensitive
data. The orders obtained in these
matters contain strong injunctive
provisions, including new requirements
that go beyond requirements from
previous data security orders. For
example, the orders include
requirements that a senior officer
provide annual certifications of
compliance to the Commission, and
explicit provisions prohibiting the
defendants from making
1 Although
the Commission’s settlement with iDressup addresses broader COPPA violations, this
statement focuses specifically on the data security
requirements set forth in the proposed stipulated
order.
VerDate Sep<11>2014
19:24 Apr 30, 2019
Jkt 247001
misrepresentations to the third parties
conducting assessments of their data
security programs. These new
requirements will provide greater
assurances that consumers’ data will be
protected going forward.
Since joining the Commission, we
have instructed staff to closely review
our orders to determine whether they
could be strengthened and improved—
particularly in the areas of privacy and
data security. Through ongoing
discussions both internally and with
external stakeholders, including through
our public Hearings on Competition and
Consumer Protection in the 21st Century
and the comment process,2 we continue
to consider changes to our orders. We
will adjust our data security orders, as
needed, to reflect our ongoing
discussions regarding the FTC’s
remedial authority and needs, as well as
the specific facts and circumstances of
each case.
We are particularly committed to
strengthening the order provisions
regarding data security assessments of
companies by third parties. The
Commission expects that these third
parties will faithfully assess data
security practices to identify potential
noncompliance with appropriate order
provisions. Future orders will better
ensure that third-party assessors know
they are accountable for providing
meaningful, independent analysis of the
data practices under examination. The
announcements today reflect the
beginning of our thinking, but we
anticipate further refinements, and these
orders may not reflect the approach that
we intend to use in every data security
enforcement action going forward.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ
Subcommittee Meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
SUMMARY:
2 See, e.g., FTC Hearings on Competition and
Consumer Protection in the 21st Century (Session
9—Data Security), Dec. 11–12, 2018, https://
www.ftc.gov/news-events/events-calendar/ftchearing-competition-consumer-protection-21stcentury-december-2018.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
meetings. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting.
DATES: See below for dates of meetings:
1. Health System and Value Research
(HSVR)
Date: May 22, 2019 (Open from 8:00
a.m. to 8:30 a.m. on May 22nd and
closed for remainder of the meeting)
2. Health Care Research and Training
(HCRT)
Date: May 23–24, 2019 (Open from
8:00 a.m. to 8:30 a.m. on May 23rd
and closed for remainder of the
meeting)
3. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: June 5–6, 2019 (Open from 8:30
a.m. to 9:00 a.m. on June 5th and
closed for remainder of the meeting)
4. Healthcare Information Technology
Research (HITR)
Date: June 6–7, 2019 (Open from 8:00
a.m. to 8:30 a.m. on June 6th and
closed for remainder of the meeting)
5. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: June 12–13, 2019 (Open from
7:30 a.m. to 8:00 a.m. on June 12th
and closed for remainder of the
meeting)
Hilton Rockville &
Executive Meeting Center, 1750
Rockville Pike, Rockville, Maryland
20852.
ADDRESSES:
(To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Heather Phelps, Acting Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427–
1128.
SUPPLEMENTARY INFORMATION: In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5
U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committees. Each subcommittee
meeting will commence in open session
before closing to the public for the
duration of the meeting. The
subcommittee meetings will be closed to
the public in accordance with the
provisions set forth in 5 U.S.C. App. 2
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). The grant applications
and the discussions could disclose
confidential trade secrets or commercial
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\01MYN1.SGM
01MYN1
Federal Register / Vol. 84, No. 84 / Wednesday, May 1, 2019 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Gopal Khanna,
Director.
[FR Doc. 2019–08764 Filed 4–30–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project ‘‘Safety
Program in Perinatal Care (SPPC)–II
Demonstration Project.’’
DATES: Comments on this notice must be
received by July 1, 2019.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
emails at doris.lefkowitz@
AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
jbell on DSK30RV082PROD with NOTICES
Proposed Project
Safety Program in Perinatal Care
(SPPC)–II Demonstration Project
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
Maternal mortality and severe maternal
morbidity (SMM) increased significantly
and continuously in the United States
(U.S.) over the past 30 years. A
considerable proportion of these adverse
events are attributable to preventable
harm and unintended consequences
VerDate Sep<11>2014
19:24 Apr 30, 2019
Jkt 247001
arising from clinical practice and the
system of delivering perinatal care. To
address these alarming trends, AHRQ
has developed the Safety Program in
Perinatal Care (SPPC). During its initial
phase (SPPC–I), the program was
comprised of three pillars: Teamwork
and communication, patient safety
bundles, and in situ simulations.
Despite several promising results, the
evaluation of SPPC–I revealed
considerable hospital attrition due to
heavy data burden and competing safety
initiatives. Also, differences in the local
adaptation of the SPPC–I patient safety
bundles selected by implementation
sites thwarted a meaningful cross-site
comparison of programmatic impact.
The current, second phase of the
program (SPPC–II), focuses on
integrating the teamwork and
communication pillar into patient safety
bundles developed by key professional
organizations and implemented in 20+
U.S. states with technical assistance by
the Alliance for Innovation on Maternal
Health (AIM) program and funding from
the Health Resources and Services
Administration (HRSA). Of note, the
model used by AIM to implement these
bundles is through statewide perinatal
quality collaboratives (PQC) aiming to
enroll all birthing hospitals in the state
in the PQC.
During the Planning Phase of SPPC–
II, the contractor, Johns Hopkins
University (JHU), developed SPPC–II
Training Toolkits for two AIM patient
safety bundles: Obstetric hemorrhage
and severe hypertension in pregnancy.
The aim of the SPPC–II Demonstration
Project is to implement and evaluate an
integrated AIM–SPPC II program that
overlays the SPPC–II Training Toolkits
and the AIM patient safety bundles and
program infrastructure in two states—
Oklahoma (OK), currently implementing
the severe hypertension bundle; and
Texas (TX), currently implementing the
hemorrhage bundle.
Over the next five years, the AIM
program is expected to cover about two
thirds of U.S. states. Therefore, there is
need to determine the feasibility and
impact of the proposed integrated AIM–
SPPC II program, and inform future
government funding decisions regarding
these two programs.
To this end, the SPPC–II
Demonstration Project has the following
goals:
(1) To implement the integrated AIM–
SPPC II program in birthing hospitals in
OK and TX in coordination with AIM
and the respective state PQC;
(2) To assess the implementation of
the integrated AIM–SPPC II program in
these hospitals; and
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
18541
(3) To ascertain the short- and
medium-term impact of the integrated
AIM–SPPC II program on hospital (i.e.
perinatal unit) teamwork and
communication, patient safety, and key
maternal health outcomes.
This study is being conducted by
AHRQ through its contractor, Johns
Hopkins University (JHU) and the AIM
program, JHU’s subcontractor, pursuant
to AHRQ’s statutory authority to
conduct and support research on health
care and on systems for the delivery of
such care, including activities with
respect to the quality, effectiveness,
efficiency, appropriateness and value of
health care services and with respect to
quality measurement and improvement.
42 U.S.C. 299a (a)(1) and (2).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(a) Training of AIM Team Leads from
48 birthing hospitals in OK and 210
birthing hospitals in TX (i.e., all birthing
hospitals enrolled in the respective state
PQC) on using teamwork and
communication tools and strategies in
clinical obstetric practice. The training
will be conducted in-person, through a
full-day workshop organized in
collaboration and coordination with the
AIM program and state PQCs, and led
by JHU. Only one such training
workshop will be conducted in OK
using the SPPC–II Toolkit for severe
hypertension in pregnancy. Given the
size of the state, potential long distances
to be traveled by trainees, and the costefficiency of coordinating with back-toback regional PQC meetings planned in
TX this fall, five training workshops
will be conducted in this state using the
SPPC–II Toolkit for obstetric
hemorrhage. We expect about half of the
birthing hospitals in both states to send
2 hospital champions, of which one to
be designated as AIM Team Lead, for
training. JHU will keep and bi-annually
update a roster of AIM Team Leads in
each hospital to assess the need for
training of new AIM Team Leads if
turnover occurs. Training workshop
evaluation forms will be distributed for
completion by trainees on a voluntary
basis to assess the perceived utility of
training workshops.
(b) Training of all frontline clinical
staff in 48 birthing hospitals in OK and
210 birthing hospitals in TX on
teamwork and communication tools and
strategies will be coordinated by AIM
Team Leads in each hospital by: (a)
Providing unique trainee IDs and
information for them to access 8 training
e-modules online, and (b) using the
JHU-developed facilitator guide
E:\FR\FM\01MYN1.SGM
01MYN1
Agencies
[Federal Register Volume 84, Number 84 (Wednesday, May 1, 2019)]
[Notices]
[Pages 18540-18541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08764]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality Notice of Meetings
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ Subcommittee Meetings.
-----------------------------------------------------------------------
SUMMARY: The subcommittees listed below are part of AHRQ's Health
Services Research Initial Review Group Committee. Grant applications
are to be reviewed and discussed at these meetings. Each subcommittee
meeting will commence in open session before closing to the public for
the duration of the meeting.
DATES: See below for dates of meetings:
1. Health System and Value Research (HSVR)
Date: May 22, 2019 (Open from 8:00 a.m. to 8:30 a.m. on May 22nd
and closed for remainder of the meeting)
2. Health Care Research and Training (HCRT)
Date: May 23-24, 2019 (Open from 8:00 a.m. to 8:30 a.m. on May 23rd
and closed for remainder of the meeting)
3. Healthcare Effectiveness and Outcomes Research (HEOR)
Date: June 5-6, 2019 (Open from 8:30 a.m. to 9:00 a.m. on June 5th
and closed for remainder of the meeting)
4. Healthcare Information Technology Research (HITR)
Date: June 6-7, 2019 (Open from 8:00 a.m. to 8:30 a.m. on June 6th
and closed for remainder of the meeting)
5. Healthcare Safety and Quality Improvement Research (HSQR)
Date: June 12-13, 2019 (Open from 7:30 a.m. to 8:00 a.m. on June
12th and closed for remainder of the meeting)
ADDRESSES: Hilton Rockville & Executive Meeting Center, 1750 Rockville
Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda
or minutes of the non-confidential portions of the meetings.)
Heather Phelps, Acting Committee Management Officer, Office of
Extramural Research Education and Priority Populations, Agency for
Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427-1128.
SUPPLEMENTARY INFORMATION: In accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific peer review groups, which are
subcommittees of AHRQ's Health Services Research Initial Review Group
Committees. Each subcommittee meeting will commence in open session
before closing to the public for the duration of the meeting. The
subcommittee meetings will be closed to the public in accordance with
the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the
discussions could disclose confidential trade secrets or commercial
[[Page 18541]]
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Agenda items for these meetings are subject to change as priorities
dictate.
Gopal Khanna,
Director.
[FR Doc. 2019-08764 Filed 4-30-19; 8:45 am]
BILLING CODE 4160-90-P